301 related articles for article (PubMed ID: 34666923)
1. The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence.
Chen MH; Chang PC
J Formos Med Assoc; 2022 May; 121(5):879-885. PubMed ID: 34666923
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F
J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of mouthwashes on reducing SARS-CoV-2 viral load in oral cavity: a systematic review and meta-analysis.
Ebrahimi T; Shamshiri AR; Alebouyeh M; Mohebbi SZ
BMC Oral Health; 2023 Jul; 23(1):443. PubMed ID: 37400836
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of mouthwash on reducing salivary SARS-CoV-2 viral load and clinical symptoms: a systematic review and meta-analysis.
Zhang M; Meng N; Duo H; Yang Y; Dong Q; Gu J
BMC Infect Dis; 2023 Oct; 23(1):678. PubMed ID: 37821800
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
[TBL] [Abstract][Full Text] [Related]
6. Povidone-Iodine as a Pre-Procedural Mouthwash to Reduce the Salivary Viral Load of SARS-CoV-2: A Systematic Review of Randomized Controlled Trials.
Garcia-Sanchez A; Peña-Cardelles JF; Ordonez-Fernandez E; Montero-Alonso M; Kewalramani N; Salgado-Peralvo AO; Végh D; Gargano A; Parra G; Guerra-Guajardo LI; Kozuma W
Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270569
[TBL] [Abstract][Full Text] [Related]
7. Oral antiseptics against coronavirus: in-vitro and clinical evidence.
Mateos-Moreno MV; Mira A; Ausina-Márquez V; Ferrer MD
J Hosp Infect; 2021 Jul; 113():30-43. PubMed ID: 33865974
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effect of mouthwashes against SARS-COV-2: A systematic review.
Mezarina Mendoza JPI; Trelles Ubillús BP; Salcedo Bolívar GT; Castañeda Palacios RDP; Herrera Lopez PSG; Padilla Rodríguez DA; Uchima Koecklin KH
Saudi Dent J; 2022 Mar; 34(3):167-193. PubMed ID: 35125835
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials.
D'Amico F; Moro M; Saracino M; Marmiere M; Cilona MB; Lloyd-Jones G; Zangrillo A
Mol Oral Microbiol; 2023 Jun; 38(3):171-180. PubMed ID: 36808889
[TBL] [Abstract][Full Text] [Related]
10. The effect of mouthrinses on severe acute respiratory syndrome coronavirus 2 viral load: A systematic review.
Silva A; Azevedo M; Sampaio-Maia B; Sousa-Pinto B
J Am Dent Assoc; 2022 Jul; 153(7):635-648.e16. PubMed ID: 35287944
[TBL] [Abstract][Full Text] [Related]
11. Oral mouthwashes for asymptomatic to mildly symptomatic adults with COVID-19 and salivary viral load: a randomized, placebo-controlled, open-label clinical trial.
Onozuka D; Takatera S; Matsuo H; Yoshida H; Hamaguchi S; Yamamoto S; Sada RM; Suzuki K; Konishi K; Kutsuna S
BMC Oral Health; 2024 Apr; 24(1):491. PubMed ID: 38664718
[TBL] [Abstract][Full Text] [Related]
12. The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses.
Saud Z; Tyrrell VJ; Zaragkoulias A; Protty MB; Statkute E; Rubina A; Bentley K; White DA; Rodrigues PDS; Murphy RC; Köfeler H; Griffiths WJ; Alvarez-Jarreta J; Brown RW; Newcombe RG; Heyman J; Pritchard M; Mcleod RW; Arya A; Lynch CA; Owens D; Jenkins PV; Buurma NJ; O'Donnell VB; Thomas DW; Stanton RJ
J Lipid Res; 2022 Jun; 63(6):100208. PubMed ID: 35436499
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of
Idrees M; McGowan B; Fawzy A; Abuderman AA; Balasubramaniam R; Kujan O
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231450
[TBL] [Abstract][Full Text] [Related]
14. CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva.
Anderson ER; Patterson EI; Richards S; Pitol AK; Edwards T; Wooding D; Buist K; Green A; Mukherjee S; Hoptroff M; Hughes GL
J Med Microbiol; 2022 Feb; 71(2):. PubMed ID: 35180046
[No Abstract] [Full Text] [Related]
15. Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial.
Alemany A; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Ouchi D; Laporte-Villar C; Baro B; Henríquez N; Prat N; Gianinetto MO; Gutiérrez MV; Sánchez-Paniagua MG; Henríquez NL; Vicente JM; Ara J; Rodriguez-Arias MA; Puig J; Blanco I; Lopez CC; Hernández Á; Bordoy AE; Redondo CE; Soler VG; Giménez M; Blanc V; León R; Gispert J; ; Clotet B; Izquierdo-Useros N; Mitjà O
J Dent Res; 2022 Nov; 101(12):1450-1456. PubMed ID: 35727681
[TBL] [Abstract][Full Text] [Related]
16. Virucidal efficacy of chlorhexidine: a systematic review.
Fernandez MDS; Guedes MIF; Langa GPJ; Rösing CK; Cavagni J; Muniz FWMG
Odontology; 2022 Apr; 110(2):376-392. PubMed ID: 34637092
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the effect of gargling with hydrogen peroxide and povidone-iodine on salivary viral load of SARS-CoV-2: A pilot randomized clinical trial.
Adl A; Sedigh-Shams M; Jamalidoust M; Rajabzadeh Z
Niger J Clin Pract; 2023 Apr; 26(4):391-396. PubMed ID: 37203101
[TBL] [Abstract][Full Text] [Related]
18. Could certain mouthwashes reduce transmissibility of COVID-19?
Elmahgoub F; Coll Y
Evid Based Dent; 2021 Jan; 22(2):82-83. PubMed ID: 34172918
[TBL] [Abstract][Full Text] [Related]
19. Effective
Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
[TBL] [Abstract][Full Text] [Related]
20. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
Khan MM; Parab SR; Paranjape M
Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]